From Product Vision to Pharma-Ready Commercial Launch

I help health tech startups navigate the complex path from innovative technology to trusted pharma vendor.

For 20+ years, I've built clinical trial technology from a 15-person startup through two acquisitions to global market leadership. Now I guide health tech founders through the complex path from innovative product to trusted pharma vendor - from commercialization strategy (product readiness, market positioning, competitive differentiation, go-to-market execution) through operational strategy for end-to-end product implementation and scaling.

Karen Maduschke, Principal of ClinTech Strategy Partners
📍 Meet me at health.tech global summit - Basel, March 3-5, 2026 Schedule a Meeting

Why Is Pharma Market Entry So Hard?

Most health tech founders underestimate the complexity. Here's what you're actually facing:

Complex Stakeholder Landscape

Clinical Operations wants different proof points than Regulatory. IT/Security has different concerns than Procurement. Your pitch needs to work across 5-8 stakeholder groups simultaneously.

Product Gaps You Don't Know About

You think you're ready. Then pharma asks for validation packages, SOC 2 Type II, CDISC mapping, eTMF integration - and you realize you're 6-12 months from delivering.

Crowded, Competitive Market

Well-established players plus a dozen well-funded startups are ahead in the game. Plus pharma's "build it ourselves" option. Generic differentiation won't cut it.

Regulatory Complexity Across Markets

FDA requirements differ from EMA and MHRA. European GDPR adds another layer. The Japanese PMDA has unique expectations. Most US founders underestimate European and Asian compliance complexity.

Aggressive Timelines Meet Slow Reality

Investor pressure says "10 pilots in Q1." Pharma sales cycles say "4-6 months minimum, often 12+." The gap between expectation and reality turns a strong value proposition into a credibility problem before it ever gets a fair hearing.

Scaling Too Late or Too Soon

More engineers first or a sales team? Time for project managers or customer service? You can't afford to hire people too soon, nor can you afford to fail on a landed contract because you lack the resources to deliver.

How Do You Navigate These Landmines?

You can leverage my experience.

I've built, scaled, and exited what you're trying to create. Having navigated the health tech journey from product development through regulatory audits to competitive positioning, I can save you the decade-long learning curve I lived.

Market Readiness Assessment

Diagnose the gap between "we have a product" and "pharma will buy it" before you waste 12 months learning the hard way.

Commercialization Strategy

Three-phase engagement: product audit, market opportunity blueprint, go-to-market roadmap. Built-in decision gates to de-risk your investment.

Fractional Leadership

Experienced strategic, operational or comercial leadership embedded in your team part-time on retainer basis when you can't justify (or afford) a full-time CxO.

Why ClinTech Strategy Partners

Deep domain expertise meets strategic partnership - guiding health tech innovators through complex biopharma market entry.

When projects require specialized expertise - whether in health economics, regulatory science, or technical architecture - I draw on a curated network of domain specialists to ensure you get precisely the right guidance.

Two Decades of Clinical Technology Expertise

From pioneering the world's first eConsent to positioning companies through successful acquisitions, I bring comprehensive understanding of clinical operations workflows, technology integration ecosystems, and the enterprise buying criteria that matter to pharma decision-makers.

Transatlantic Market Knowledge

Built and scaled clinical technology products across US, European, and Asian markets. My direct experience with FDA, EMA & PMDA requirements, including health tech audits and regulatory submissions, provides practical guidance beyond theoretical compliance.

Risk-Mitigated Engagement Model

Structured phased approaches with clear decision gates, milestone-based deliverables, and transparent trade-off analysis. You maintain control of your investment while building toward measurable outcomes.

Global Reach with European Presence

Based in Germany with full German fluency, yet flexible to accommodate US or APAC business hours for seamless real-time collaboration. Your teams work efficiently without timezone friction.

Candor That Protects Your Investment

If your product isn't ready for market entry, you'll hear it directly - along with a clear roadmap of what needs to happen first. This honest assessment has helped founders avoid millions in premature market spend and damaged relationships with key prospects.

Collaborative Problem-Solving Partner

I work alongside your team as an active thought partner, not a detached advisor. Expect challenging questions, framework-driven discussions, and collaborative working sessions that build your team's strategic capabilities while driving decisions forward.

About Karen

Ready to Explore More?

Schedule an introductory call. We will discuss your needs and how I could help. If the fit feels right, I'll provide a written proposal for you and your board to review. No sales pitch. Just honest guidance from someone who's lived your journey.

Schedule a Call